New patent expiration for Novartis Pharms drug ENTRESTO
Drug Patent Watch
MAY 26, 2024
Annual Drug Patent Expirations for ENTRESTO Entresto is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from two suppliers.
Sun.May 26, 2024
59 
Hope for MDD: An Invitation to Help Researchers Shape the Future of Treatment
Trialfacts
MAY 26, 2024
Contents About the Study Why Participate? Your Rights Who Can Participate? More Study Details About the Research Center Study Location Research Center: Collective Medical Research Location: 7501 College Blvd, Suite 100, Overland Park, KS 66210 Lead Researcher: Dr. Haydn Mikel Thomas, M.D. IRB: This study has been reviewed and approved by the Advarra Institutional Review Board About the Study Are you or someone you know struggling with Major Depressive Disorder (MDD)?
Capsule dosed drug patent expirations by year
Drug Patent Watch
MAY 26, 2024
This chart shows the patent expirations for capsule dosed drugs over the next decade. The term of drug patents varies.
Let's personalize your content